paclitaxel has been researched along with Fibrosarcoma in 27 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 8 (29.63) | 18.2507 |
| 2000's | 10 (37.04) | 29.6817 |
| 2010's | 8 (29.63) | 24.3611 |
| 2020's | 1 (3.70) | 2.80 |
| Authors | Studies |
|---|---|
| Asao, Y; Matsuda, H; Miyagawa, K; Nakashima, S; Takayama, S; Xu, F; Yoshida, K; Yoshikawa, M | 1 |
| Kim, KS; Lee, T; Na, K | 1 |
| Cai, X; Mei, X; Xie, X; Yang, Y | 1 |
| Baba, J; Ichikawa, K; Igarashi, N; Ishikawa, D; Kagamu, H; Kondo, R; Koshio, J; Koya, T; Miura, S; Nakata, K; Narita, I; Nozaki, K; Okajima, M; Saida, Y; Sato, K; Shoji, S; Tanaka, J; Tanaka, T; Watanabe, S; Yoshizawa, H | 1 |
| Barback, CV; Callmann, CE; Gianneschi, NC; Hall, DJ; Mattrey, RF; Thompson, MP | 1 |
| Bhonagiri, S; Engblom, C; Farokhzad, OC; Gadde, S; Kamaly, N; Kohler, RH; Laughney, AM; Miller, MA; Pfirschke, C; Pittet, MJ; Sprachman, MM; Weissleder, R; Wojtkiewicz, G; Yang, KS | 1 |
| Kanada, M; Nagasaki, A; Uyeda, TQ | 1 |
| Babo, I; Harisi, R; Jeney, A; Kenessey, I; Olah, JN; Paku, S; Pogany, G; Timar, F | 1 |
| Anchoori, RK; Khan, SR; Kostova, MB; Neamati, N; Xu, S; Yamada, R | 1 |
| Ferrone, S; Gao, H; Ioannides, CG; Li, Y; Matsueda, S; Mine, T; Peoples, GE; Wong, KK | 1 |
| Chang, HL; Donahoe, PK; Li, X; MacLaughlin, DT; Nicolaou, F; Pieretti-Vanmarcke, R; Wei, X | 1 |
| Du, R; Duan, Y; Huang, Y; Luo, LM; Song, P; Yu, KF; Zhang, Q; Zhang, X; Zhao, BX; Zhao, X; Zhao, Y | 1 |
| Banskota, AH; Kadota, S; Kouda, K; Nguyen, NT; Tezuka, Y; Usia, T | 1 |
| Dicker, AP; Grant, DS; Williams, TL; Zahaczewsky, M | 1 |
| Marchettini, P; Mohamed, F; Stuart, OA; Sugarbaker, PH; Urano, M | 1 |
| Cvetkovic, I; Harhaji, L; Markovic, M; Miljkovic, D; Sajic, M; Trajkovic, V; Vuckovic, O | 1 |
| Choi, GS; Im, MW; Kil, HY; Kim, CS; Kim, SK; Kim, WC; Lee, HS; Lee, JR; Lee, MG; Lee, MH; Seong, DH; Song, SU | 1 |
| Corti, A; Curnis, F; Gallo-Stampino, C; Gasparri, A; Sacchi, A; Toma, S | 1 |
| Bae, JS; Chi, DY; Choe, YS; Jung, KH; Kim, DH; Ko, BH; Lee, BC; Lee, KH; Paik, JY; Sung, HJ | 1 |
| Berman, JW; Burkhart, CA; Horwitz, SB; Swindell, CS | 1 |
| Alleva, DG; Burger, CJ; Elgert, KD; Mullins, DW | 1 |
| Burger, CJ; Elgert, KD; Mullins, DW; Walker, TM | 1 |
| Chahinian, AP; Gluck, H; Holland, JF; Mandeli, JP; Naim, H; Teirstein, AS | 1 |
| Cao, S; Harstrick, A; Rustum, YM; Seeber, S; Vanhoefer, U | 1 |
| Adhikari, D; Banerjee, D; Bertino, JR; Fu, JZ; Schnieders, B; Zhao, SC | 1 |
| Higuchi, T; Hunter, N; Inoue, T; Kim, EE; Li, C; Milas, L; Oriuchi, N; Podoloff, DA; Wallace, S; Yang, DJ; Yu, D | 1 |
| Han, R; Lei, X; Liu, H | 1 |
27 other study(ies) available for paclitaxel and Fibrosarcoma
| Article | Year |
|---|---|
Rotenoids and flavonoids with anti-invasion of HT1080, anti-proliferation of U937, and differentiation-inducing activity in HL-60 from Erycibe expansa.
Topics: Cell Differentiation; Cell Proliferation; Convolvulaceae; Enzyme Precursors; Fibrosarcoma; Flavonoids; Gelatinases; HL-60 Cells; Humans; Matrix Metalloproteinase 9; Metalloendopeptidases; Neoplasm Invasiveness; Plant Extracts; Rotenone; Tumor Cells, Cultured; U937 Cells | 2007 |
Nanocracker capable of simultaneously reversing both P-glycoprotein and tumor microenvironment.
Topics: Adenocarcinoma; Adenosine Triphosphatases; Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line, Tumor; Drug Delivery Systems; Drug Resistance, Neoplasm; Fibrosarcoma; Humans; Mice; Paclitaxel; Pantoprazole; Tumor Microenvironment | 2023 |
Preparation and characterization of photo-responsive cell-penetrating peptide-mediated nanostructured lipid carrier.
Topics: Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell-Penetrating Peptides; Drug Carriers; Drug Delivery Systems; Drug Stability; Fibrosarcoma; Humans; Lipids; Nanostructures; Paclitaxel; Particle Size; Tumor Microenvironment; Ultraviolet Rays | 2014 |
Critical Roles of Chemoresistant Effector and Regulatory T Cells in Antitumor Immunity after Lymphodepleting Chemotherapy.
Topics: Adoptive Transfer; Animals; Cisplatin; Cyclophosphamide; Cytotoxins; Deoxycytidine; Drug Resistance; Etoposide; Female; Fibrosarcoma; Gemcitabine; Lymph Nodes; Lymphocyte Depletion; Lymphopenia; Methylcholanthrene; Mice; Mice, Inbred C57BL; Mice, Knockout; Paclitaxel; T-Lymphocytes, Cytotoxic; T-Lymphocytes, Regulatory; Tumor Cells, Cultured; Vidarabine; Whole-Body Irradiation | 2015 |
Therapeutic Enzyme-Responsive Nanoparticles for Targeted Delivery and Accumulation in Tumors.
Topics: Animals; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cohort Studies; Drug Carriers; Drug Evaluation, Preclinical; Fibrosarcoma; Fluorescence Resonance Energy Transfer; Humans; Matrix Metalloproteinases; Maximum Tolerated Dose; Mice, Nude; Micelles; Microscopy, Electron, Transmission; Nanoparticles; Neoplasm Transplantation; Optical Imaging; Paclitaxel; Polymers; Tumor Burden | 2015 |
Predicting therapeutic nanomedicine efficacy using a companion magnetic resonance imaging nanoparticle.
Topics: Animals; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Chemistry, Pharmaceutical; Disease Progression; DNA Damage; Female; Ferrosoferric Oxide; Fibrosarcoma; Humans; Macrophages; Magnetic Resonance Imaging; Magnetics; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Nude; Mice, Transgenic; Nanomedicine; Nanoparticles; Ovarian Neoplasms; Paclitaxel; Particle Size; Polyethylene Glycols; Polyglactin 910; Predictive Value of Tests; Time Factors; Tissue Distribution; Tumor Microenvironment; Xenograft Model Antitumor Assays | 2015 |
Stabilization of anaphase midzone microtubules is regulated by Rho during cytokinesis in human fibrosarcoma cells.
Topics: Anaphase; Animals; Cell Line, Tumor; Cytokinesis; Enzyme Activation; Fibrosarcoma; Heterocyclic Compounds, 4 or More Rings; Humans; Microtubule-Associated Proteins; Microtubules; Nocodazole; Paclitaxel; Proto-Oncogene Proteins; rho GTP-Binding Proteins; RNA Interference; Spindle Apparatus; Tubulin Modulators | 2009 |
Differential inhibition of single and cluster type tumor cell migration.
Topics: Adolescent; Bone Neoplasms; Cell Culture Techniques; Cell Movement; Cell Proliferation; Chromones; Deoxyuridine; Enzyme Inhibitors; Extracellular Signal-Regulated MAP Kinases; Fibrosarcoma; Flavonoids; Humans; Imidazoles; Male; Morpholines; Okadaic Acid; Osteosarcoma; p38 Mitogen-Activated Protein Kinases; Paclitaxel; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Pyridines; Signal Transduction; Tumor Cells, Cultured | 2009 |
Biological evaluation of paclitaxel-peptide conjugates as a model for MMP2-targeted drug delivery.
Topics: Animals; Antineoplastic Agents, Phytogenic; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Colony-Forming Units Assay; Drug Delivery Systems; Drug Resistance, Neoplasm; Fibrosarcoma; Humans; Matrix Metalloproteinase 2; Mice; Mice, Nude; Oligopeptides; Paclitaxel; Prodrugs; Sarcoma, Experimental; Xenograft Model Antitumor Assays | 2010 |
Created Gli-1 duplex short-RNA (i-Gli-RNA) eliminates CD44 Hi progenitors of taxol-resistant ovarian cancer cells.
Topics: Antineoplastic Agents, Phytogenic; Blotting, Western; Calcium-Binding Proteins; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Female; Fibrosarcoma; Flow Cytometry; Humans; Hyaluronan Receptors; Intercellular Signaling Peptides and Proteins; Membrane Proteins; Ovarian Neoplasms; Paclitaxel; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Small Interfering; Serrate-Jagged Proteins; Stem Cells; Transcription Factors; Zinc Finger Protein GLI1 | 2010 |
Mullerian inhibiting substance inhibits invasion and migration of epithelial cancer cell lines.
Topics: Animals; Anti-Mullerian Hormone; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Chick Embryo; Chorioallantoic Membrane; Dose-Response Relationship, Drug; Female; Fibrosarcoma; Head and Neck Neoplasms; Humans; Neoplasm Invasiveness; Neoplasms; Ovarian Neoplasms; Paclitaxel; Receptors, Peptide; Receptors, Transforming Growth Factor beta | 2011 |
Anti-tumor and anti-angiogenic effect of metronomic cyclic NGR-modified liposomes containing paclitaxel.
Topics: Administration, Metronomic; Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Diffusion; Female; Fibrosarcoma; Humans; Liposomes; Metabolic Clearance Rate; Mice; Mice, Inbred BALB C; Mice, Nude; Nanocapsules; Oligopeptides; Organ Specificity; Paclitaxel; Rats; Rats, Sprague-Dawley; Tissue Distribution; Treatment Outcome | 2013 |
Three new C-14 oxygenated taxanes from the wood of Taxus yunnanensis.
Topics: Animals; Antineoplastic Agents, Phytogenic; Bridged-Ring Compounds; Cell Survival; Colonic Neoplasms; Diterpenes; Drug Screening Assays, Antitumor; Drugs, Chinese Herbal; Fibrosarcoma; Humans; Hydrolysis; Mice; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Paclitaxel; Plants, Medicinal; Stereoisomerism; Taxoids; Taxus; Trees; Tumor Cells, Cultured | 2002 |
Comparison of antiangiogenic activities using paclitaxel (taxol) and docetaxel (taxotere).
Topics: Angiogenesis Inhibitors; Animals; Aorta; Apoptosis; Capillaries; Carcinoma, Non-Small-Cell Lung; Cell Differentiation; Cell Division; Cells, Cultured; Chemotaxis; Docetaxel; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Endothelium, Vascular; Fibrosarcoma; Glioblastoma; Humans; Lung Neoplasms; Male; Melanoma; Mice; Mice, Nude; Neoplasm Transplantation; Paclitaxel; Rats; Taxoids; Tumor Cells, Cultured; Umbilical Veins; Xenograft Model Antitumor Assays | 2003 |
Thermal enhancement of new chemotherapeutic agents at moderate hyperthermia.
Topics: Animals; Antineoplastic Agents; Camptothecin; Deoxycytidine; Drug Screening Assays, Antitumor; Fibrosarcoma; Gemcitabine; Hyperthermia, Induced; Irinotecan; Melphalan; Mice; Mice, Inbred C3H; Organoplatinum Compounds; Oxaliplatin; Paclitaxel | 2003 |
5-Aza-2'-deoxycytidine and paclitaxel inhibit inducible nitric oxide synthase activation in fibrosarcoma cells.
Topics: Animals; Azacitidine; Cell Line, Tumor; Decitabine; Dose-Response Relationship, Drug; Enzyme Inhibitors; Fibrosarcoma; Mice; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Paclitaxel | 2004 |
Combined treatment of an intratumoral injection of dendritic cells and systemic chemotherapy (Paclitaxel) for murine fibrosarcoma.
Topics: Animals; Antineoplastic Agents, Phytogenic; Bone Marrow Cells; Cell Line, Tumor; Cells, Cultured; Combined Modality Therapy; Dendritic Cells; Fibrosarcoma; Immunologic Memory; Injections, Intraperitoneal; Mice; Paclitaxel; Phenotype; Transplantation, Isogeneic; Treatment Outcome | 2005 |
Synergistic antitumor activity of cisplatin, paclitaxel, and gemcitabine with tumor vasculature-targeted tumor necrosis factor-alpha.
Topics: Adenocarcinoma; Animals; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Deoxycytidine; Drug Synergism; Female; Fibrosarcoma; Gemcitabine; Lymphoma; Mice; Neoplasm Transplantation; Neoplasms; Paclitaxel; Tumor Necrosis Factor-alpha | 2006 |
Favorable biokinetic and tumor-targeting properties of 99mTc-labeled glucosamino RGD and effect of paclitaxel therapy.
Topics: Animals; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Proliferation; Drug Delivery Systems; Fibrosarcoma; Humans; Kinetics; Male; Metabolic Clearance Rate; Mice; Mice, Inbred BALB C; Mice, Nude; Oligopeptides; Organ Specificity; Paclitaxel; Radionuclide Imaging; Radiopharmaceuticals; Rats; Technetium; Tissue Distribution; Treatment Outcome | 2006 |
Relationship between the structure of taxol and other taxanes on induction of tumor necrosis factor-alpha gene expression and cytotoxicity.
Topics: Animals; Antineoplastic Agents, Phytogenic; Drug Design; Drug Screening Assays, Antitumor; Fibrosarcoma; Gene Expression Regulation, Neoplastic; Mice; Paclitaxel; RNA, Messenger; RNA, Neoplasm; Structure-Activity Relationship; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 1994 |
Taxol, a microtubule-stabilizing antineoplastic agent, differentially regulates normal and tumor-bearing host macrophage nitric oxide production.
Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Fibrosarcoma; Interferon-gamma; Lipopolysaccharides; Macrophages, Peritoneal; Male; Mice; Mice, Inbred BALB C; Microtubules; Neoplasm Transplantation; Nitric Oxide; Paclitaxel; Recombinant Proteins; Tumor Necrosis Factor-alpha; Up-Regulation | 1997 |
Taxol-mediated changes in fibrosarcoma-induced immune cell function: modulation of antitumor activities.
Topics: Animals; Antineoplastic Agents, Phytogenic; Cell Division; Cytotoxicity, Immunologic; Fibrosarcoma; Immune Tolerance; Isoantigens; Lymphocyte Activation; Macrophage Activation; Macrophages; Male; Mice; Mice, Inbred BALB C; Nitric Oxide; Paclitaxel; T-Lymphocytes | 1997 |
Effectiveness of cisplatin, paclitaxel, and suramin against human malignant mesothelioma xenografts in athymic nude mice.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Female; Fibrosarcoma; Humans; Mesothelioma; Mice; Mice, Nude; Neoplasm Transplantation; Paclitaxel; Pleural Neoplasms; Sarcoma; Suramin; Transplantation, Heterologous; Tumor Cells, Cultured | 1998 |
Comparative antitumor efficacy of docetaxel and paclitaxel in nude mice bearing human tumor xenografts that overexpress the multidrug resistance protein (MRP)
Topics: Animals; Antineoplastic Agents, Phytogenic; ATP-Binding Cassette Transporters; Docetaxel; Fibrosarcoma; Gene Expression Regulation, Neoplastic; Humans; Mice; Mice, Nude; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Paclitaxel; Sarcoma, Experimental; Taxoids; Transplantation, Heterologous; Tumor Cells, Cultured; Up-Regulation | 1997 |
Role of E2F-1 in chemosensitivity.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Camptothecin; Carrier Proteins; Cell Cycle; Cell Cycle Proteins; Cell Division; Cell Survival; Cloning, Molecular; Culture Media, Serum-Free; DNA-Binding Proteins; Doxorubicin; E2F Transcription Factors; E2F1 Transcription Factor; Etoposide; Fibrosarcoma; Humans; Irinotecan; Paclitaxel; Recombinant Proteins; Retinoblastoma-Binding Protein 1; Tetrahydrofolate Dehydrogenase; Transcription Factor DP1; Transcription Factors; Transfection; Tumor Cells, Cultured | 1998 |
Evaluation of In-111 DTPA-paclitaxel scintigraphy to predict response on murine tumors to paclitaxel.
Topics: Animals; Carcinoma, Squamous Cell; Drug Resistance, Neoplasm; Female; Fibrosarcoma; Liver; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Ovarian Neoplasms; Paclitaxel; Pentetic Acid; Radionuclide Imaging; Rats | 1999 |
[Anti-invasion activity of several plant-originated anticancer drugs with different mechanism of action].
Topics: Animals; Antineoplastic Agents; Camptothecin; Cell Division; Cell Movement; Fibrosarcoma; Harringtonines; Homoharringtonine; Humans; Melanoma, Experimental; Mice; Neoplasm Invasiveness; Paclitaxel; Plant Bark; Plant Roots; Taxus; Tumor Cells, Cultured | 1998 |